Lethal yellow (hi y) is a mutation at the mouse agouti (a) locus that is associated with an all-yellow coat color, obesity, diabetes, tumors in heterozygotes, and preimplantation embryonic lethality in homozygotes. Previously, we cloned and characterized the wild-type agouti gene and demonstrated that it expresses a 0.8-kb mRNA in neonatal skin. In contrast, A y expresses a 1.1-kb transcript that is ectopically overexpressed in all tissues examined. The A y mRNA is identical to the wild-type a transcript for the entire coding region, but the 5'-untranslated sequence of the a gene has been replaced by novel sequence. Here, we demonstrate that the novel 5' sequence in the A y mRNA corresponds to the 5'-untranslated sequence of another gene that is normally tightly linked to a in mouse chromosome 2. This other gene (Ra/y) has the potential to encode a novel RNA-binding protein that is normally expressed in the preimplantation embryo, throughout development, and in all adult tissues examined. Importantly, the A y mutation disrupts the structure and expression of the Raly gene. The data suggest that the A y mutation arose from a DNA structural alteration that affects the expression of both agouti and Raly. We propose that the dominant pleiotropic effects associated with A ~ may result from the ectopic overexpression of the wild-type a gene product under the control of the Raly promoter and that the recessive embryonic lethality may be the result of the lack of Raly gene expression in the early embryo. 
The agouti (a) locus in mouse chromosome 2 is recognized most widely for its role in the regulation of coat pigmentation (for review, see Silvers 1979) . There are, however, several a locus mutations that also cause embryonic lethality in homozygotes, and these mutations have served as useful genetic reagents for the analysis of early mouse development (Papaioannou and Mardon 1983; Lyon et al. 1985; Papaioannou and Gardner 1992) . The most notable of these mutations is lethal yellow (AY), which dates back to the mouse fancy and derives its name from the fact that homozygotes die prenatally and heterozygotes have a completely yellow pelage. The A y mutation causes a number of dominant pleiotropic effects in addition to the yellow pelage, including obesity (Dickerson and Gowen 1947; Fenton and Chase 1951; Carpenter and Mayer 1958; Plocher and Powley 1976; Friedman and Leibel 1992) , non-insulin-dependent diabetes (Hellerstr6m and Hellman 1963) , and increased tumor susceptibility (for review, see Wolff et al. 1986; Wolff 1987) .
A • was the first mammalian mutation to be found associated with embryonic lethality, which was revealed by a modified Mendelian ratio among offspring of phenotypically yellow parents (Cu6not 1908; Castle and Little 1910; Ibsen and Steigleder 1917; Kirkham 1917 Kirkham , 1919 . Early histological studies placed the time of death of AY/A y mice between 5.5 and 6.5 days postcoitum (Robertson 1942; Eaton and Green 1963) , but subsequent experiments with preimplantation embryos in culture indicated that deleterious effects of the A y mutation may be manifested in early cleavage (Pedersen 1974; Pedersen and Spindle 1976; Granholm and Johnson 1978) . Overall, these experiments suggested that the A • mutation causes developmental defects over a range of time between early cleavage and implantation, but no tissue or stage-specific effect of the A y mutation was identified. Papaioannou and Gardner (1979) sought to determine whether A y affects either the trophectoderm or the inner cell mass (ICM) of the blastocyst exclusively or whether A y acts as a general cell lethal mutation. To address these issues, these workers constructed chimeras by transferring the ICM of an AY/A • embryo into the blastocoel cavity of a normal embryo, and vice versa. The key results from these analyses were that AY/A y ICMs survived and differentiated in normal blastocysts up to at least 10.5 days of gestation but that normal ICMs could not rescue the preimplantation lethality of A Y / A y blastocysts. Because neither the genotype nor the phenotype of the A Y / A y embryos could be unequivocally ascertained in these experiments, the investigators analyzed their data statistically and concluded that the A y mutation primarily affects the trophectoderm and does not cause a generalized cell lethality.
More recently, however, Papaioannou (1988) investigated the tissue specificity of the lethal yellow mutation further by culturing ICM and trophectoderm that had been separated from individual blastocysts derived from (AY/a e x AY/a e) and control (ae/a ~ x AY/a ~) matings. On the basis of these experiments, it was concluded that homozygosity of A y exerts a detrimental effect in both the ICM and the trophectoderm. This in vitro result is consistent with the in vivo experiments reported later by Barsh et al. (1990) , in which aggregation chimeras prepared between A Y / A y and normal morula-stage embryos were analyzed for the presence of A y with a molecular probe at day 9.5 of gestation or at birth. These experiments suggested that the lethal effects of A Y / A y cannot be rescued in a chimeric environment.
The molecular nature of the gene(s) responsible for the embryonic lethality and the dominant pleiotropic effects of A y is currently unknown. However, as part of our recently reported work involving the molecular characterization of the wild-type a gene, we made the observation that the agouti transcript expressed from the A • allele is slightly larger than the wild-type transcript. The entire coding region of the a gene is intact in the largerthan-normal A y transcript, but the first, noncoding exon of the a gene has been replaced by novel sequence (Bultman et al. 1992) . On the basis of these observations, and the fact that the A y transcript is ectopically overexpressed, we previously hypothesized that the A y allele arose through a structural alteration that caused the disruption of both the a gene and a second gene, resulting in the replacement of the normal promoter and first exon of agouti with the promoter and 5' end of the second gene (Bultman et al. 1992 ). In addition, we proposed that disruption of the a gene and its concomitant ectopic overexpression is associated with the yellow coat pigmentation and dominant pleiotropic effects of A y and that the recessive embryonic lethality is not related to the a gene per se but is instead the result of the disruption of the function of the second gene.
Here, we present a more detailed molecular analysis of the A y allele, including the cloning and characterization of that second gene, which we propose is a candidate gene responsible for the embryonic lethality of A y. This gene maps very closely to the a locus and has a broad temporal and spatial pattern of expression, which includes the blastocyst. Most importantly, the structure and expression of this gene is disrupted in the A y allele. Sequence analysis of this gene indicates that it is a member of a family of RNA-binding proteins that have been implicated in pre-mRNA processing and developmental regulation.
GENES & DEVELOPMENT R e s u l t s

The A y transcript is a chimera c o m p o s e d of agouti and a second gene
We demonstrated previously that the a gene consists of four exons and is normally expressed as a 0.8-kb transcript in neonatal skin, whereas the A y allele is expressed as an -1.1-kb transcript in neonatal skin and in all adult tissues examined to date (Bultman et al. 1992 ).
An adult kidney cDNA library was prepared from a lethal yellow heterozygote (A• e) and was screened with the wild-type agouti cDNA clone (Bultman et al. 1992) . Sequence analysis of a partial A y cDNA clone revealed that the entire coding region and 3'-untranslated sequence of the a gene is identical in the larger-than-normal A y transcript, but the first, noncoding exon of the a gene has been replaced by novel sequence (Fig. 1 ). This segment of novel 5' sequence in the A y cDNA was subsequently used as a probe (probe A, Fig. 1 ) to obtain wildtype genomic and cDNA clones. Sequence analyses of these clones revealed that the novel sequence in the A y transcript corresponds to a 5'-noncoding exon of a previously uncharacterized gene ( Fig. 1 ), which we have named Raly because it has the potential to encode an hn_RNP protein that is associated with lethal yellow (see below).
Characterization of Raly c D N A clones
To characterize the structure of the wild-type Raly gene, we screened -1.2 x 106 plaque-forming units of a day- Figure 1 . The A y allele encodes a Raly/a fusion transcript. The wild-type agouti transcript is composed of sequence derived from four exons {numbered 1-4, with their respective sizes indicated below}. The A y transcript is identical to the wild-type agouti transcript for the sequence derived from the second, third, and fourth exons {coding region), but the noncoding first exon of agouti has been replaced by the noncoding first exon of Raly (represented by the shaded region, 169 bases in length}. Probe A corresponds to sequence that was initially identified as being unique to the 5' end of the A y transcript and subsequently used to isolate wild-type Raly cDNA and genomic clones. The vertical line indicates that the replacement of the first agouti exon with the first Raly exon in the A y transcript occurs precisely at an exon-intron splice junction in both wild-type genes. The proposed sites for translation initiation in all three transcripts are indicated by AUGs.
8.5 total embryo cDNA library (Fahmer et al. 1987 ) with probe A (Fig. 1) , resulting in the identification of six clones, three of which were characterized further. Each of these three clones contains the entire coding region and appears to be full length or nearly full length. The total size of the cDNA clone presented in Figure 2 is 1517 bp and, with the addition of a poly(A) tract, would be similar in size to the 1.6-kb mRNA observed on Northern blots {see below). The cDNA contains an open reading frame (ORF) extending from nucleotide 262 through 1152, beginning with an ATG codon flanked by sequence that conforms well to the consensus for translation initiation (Kozak 1987) . The translation product deduced from the ORF is 296 amino acids in length, with an estimated molecular mass of 31.2 kD and an isoelectric point of 10.17 (Fig. 2) . Searches of the NBRF and SWISSPROT data bases, using the algorithm FASTA (Pearson and Lipman 1988) , identified both human (Swanson et al. 1987; Burd et al. 1989) and Xenopus (Preugschat and Wold 1988) heterogeneous nuclear ribonucleoprotein particle C (hnRNP C) proteins as having striking sequence similarity to Raly.
The hnRNP proteins, a family of proteins involved in pre-mRNA packaging and processing, belong to a larger family of RNA-binding proteins that are all characterized by a generally conserved domain consisting of -90 amino acids [the RNA-binding domain (RBD)] that occurs at least once in these proteins (Bandziulis et al. 1989 ). The most highly conserved segments in the RBD are an octapeptide (referred to as RNP 1) and a hexapeptide (RNP 2); these residues are indicated in the Raly sequence in Figure 2 . A comparison of the putative 99-amino-acid RBD of Raly to the 94-amino-acid RBD of human hnRNP C indicates that over a 93-residue region, these two proteins are 77% identical and 89% similar, with no gaps introduced into the alignment (Fig. 3) . However, when the remaining carboxy-terminal portions of these proteins are compared, an optimal alignment results in 37% identity and 58% similarity after introducing seven gaps (data not shown). Therefore, although the RBDs of Raly and hnRNP C share striking sequence similarity and likely have a related function within the cell, the remainder of Raly is sufficiently unique to indicate that it is not simply the mouse homolog of hnRNP C. Rather, it appears that Raly represents a novel member of the hnRNP family of proteins.
The Raly transcription unit is alternately spliced at the 5' end
Based on the analysis of Raly cDNA clones, we discovered that there are two forms of the mature Raly transcript present in the day-8.5 total embryo. These two forms differ only by the presence or absence of an 83-bp segment in the 5'-untranslated region {indicated by uppercase letters in Fig. 2 ). The form depicted in Figure 2 , containing the 83-bp segment, has in-frame termination codons upstream of the translation initiation codon. The alternate form of the Raly transcript lacks the 83-bp seg- TTCTTGGTACTGg t gaacacc I atgtccttgaagattcagaccagcaatgtaaccaacaag 300
cagattgctgaggaacagaaggccaacDccagatggcaagaagaagggtgacFgcagcagt 900
gg tggaggaggaggcagcagtggt ggaggcggcagt agcaat g t tgg t gg tggcagcagc 960 Raly. The sequence of probe A ( Fig. 1 ) is underscored by a broken line. The 83-bp region that is alternately processed in the mature transcription unit is indicated by uppercase letters. The aataaa polyadenylation signal is underscored by a solid line. A putative 99-amino-acid RBD is located at the amino terminus of the 296-amino-acid translation product and is enclosed by a box, with the highly conserved hexapeptide and octapeptide within the RBD underscored by double and single lines, respectively. The middle of the predicted protein contains a region {amino acids 120-148) where 19 of 29 residues are hydrophobic and 16 of these residues are proline or valine. Enclosed in brackets near the carboxyl terminus of the predicted protein is a hydrophillic domain where a0 of the 33 residues are glycine or serine and the domain contains two potential glycosaminoglycan attachment sites (11). The translation product contains one potential asparagine glycosylation site (O), 12 potential serine/threonine kinase phosphorylation sites {r-I), and is acidic, especially over its carboxyl terminus, where 17 of the final 47 residues are aspartic or glutamic acid. The cDNA sequence presented is a composite of two cDNA clones; cDNA 1 provided all of the sequence except for the first 59 bp, which came from cDNA 4. Fig. 1 ), which results in the removal of the upstream termination codons and the extension of the ORF from the ATG to the 5' end of the cDNA clone. Whether this extension of the ORF is functionally significant is presently unclear, but it is unlikely as there are no ATG codons present within this region.
A reverse transcriptase-polymerase chain reaction (RT-PCR) assay was used to determine whether both forms of the Raly mRNA are present in a variety of tissues, in addition to the day-8.5 total embryo. Oligonucleotide primers were prepared that correspond to base pairs 108-127 (5' to the 83-bp segment) and to the reverse complement of base pairs 457-438 (3' to the 83-bp segment) in the Raly cDNA (Fig. 2) . If both forms of the Raly mRNA are present in a given tissue, this assay is expected to result in RT-PCR products of 350 bp for the transcript containing the 83-bp segment and 267 bp for the alternate transcript that lacks this sequence. To date, the assay has been used to examine the blastocyst, neonate skin, and adult brain. The two expected size fragments were produced in each tissue, and both fragments were observed at approximately equal intensities (data not shown). The results of this assay indicate that both forms of the Raly transcript are expressed at approximately equal levels in each of these tissues.
Raly and agouti are tightly linked in chromosome 2
The observation that the A y allele expresses a chimeric transcript containing both Raly and a sequences and that the A y allele has no detectable rearrangement at the cytogenetic level (N.L.A. Cacheiro, pers. comm.)suggested that these two genes may normally be tightly linked in chromosome 2. To address this issue, genomic probes from both the Raly and a loci were hybridized to TaqIdigested DNA from 80 Mus musculus/M, spretus F1 animals (Johnson et al. 1989 ). The Raly probe identified fragments of 2.2, 1.8, and 0.9 kb in M. musculus and fragments of 3.5, 1.8, and 0.9 kb in M. spretus. The a probe identified fragments of 3.5, 1.8, 1.7, and 0.5 kb in M. musculus and a single fragment of 1.9 kb in M. spretus. The unique-sized restriction fragments allowed us to differentiate the M. musculus and M. spretus alleles.
This analysis revealed no recombinants between the
Raly and a sequences, indicating that these genes are tightly linked in chromosome 2 (95% confidence limits of 0-4.1 cM; data not shown). Moreover, preliminary pulsed-field gel electrophoresis data indicate that the 5' end of Raly lies, at most, 300 kb 5' to a (E.J. Michaud, S.J.
Bultman, L.J. Stubbs, and R.P. Woychik, unpubl.).
In an attempt to begin to analyze the structure of the DNA associated with the A y allele, we probed genomic blots with probes specific to the 5' end of agouti and to the 3' end of Raly (Fig. 4) . For the 5' end of agouti, we were able to differentiate the A y allele from the balancing nonagouti allele by exploiting a sequence polymorphism. As shown in Figure 4A , we clearly demonstrated that the 5' end of agouti in the A y allele is not deleted or 
Raly is expressed in a widespread temporal and spatial manner
Given that the 5' end of Raly has been spliced to the coding region of agouti in the A • transcript and that A y is ectopically expressed (presumably from the Raly promoter) in a widespread manner (Bultman et al. 1992) , it seemed likely that wild-type Raly would also be expressed in the same broad temporal and spatial pattern as A y. A cDNA probe was used to demonstrate that Raly is expressed as a 1.6-kb transcript in the developing embryo and fetus, in neonatal skin, and in a variety of adult tissues (Fig. 5A, B) . Both forms of the Raly transcript apparently comigrate on Northern blots because they differ in size by only 83 bases. When the Northern blot filters were washed at high stringency, only the 1.6-kb transcript was apparent in each tissue. Interestingly, when the same filter was initially washed at a reduced stringency, hybridizing fragments of -1.0, 2.3, and 2.7 kb were also present in neonatal skin (Fig. 5A) . Under the same reduced stringency conditions, these additional transcripts are also apparent in advanced-stage whole fe- tuses, possibly the result of the increased percentage of skin in the total fetal R N A (Fig. 5B) . W h e t h e r these additional transcripts represent Raly family members that are u n i q u e l y expressed in the skin or are simply unrelated skin-specific transcripts that cross-hybridize to Raly remains to be determined. Importantly, Raly is also expressed in the blastocyst (Fig. 5C) , the stage in w h i c h the recessive lethality of the A y m u t a t i o n is manifested.
The A • mutation disrupts the expression of the Raly gene
The molecular structure of the A y genomic D N A indicated that the A y m u t a t i o n contains a deletion that removes at least a portion of the Raly-coding sequences near the 3' end of the gene (Fig 4B) . To provide additional supporting evidence that Raly is not expressed from the A y allele, we tested for the expression of one type of Raly transcript in the A y allele using a m e t h o d that exploited Eighteen C57BL/6J blastocysts were collected at day 3.5 postcoitum, total RNA was prepared and reverse transcribed, and the entire coding region of the Raly mRNA was amplified by PCR with oligonucleotide primers corresponding to base pairs 108-127 (5' to the translation initiation codon) and the reverse complement of base pairs 1334-1315 {3' to the termination codon) in the Raly cDNA (Fig. 2) . The PCR product was electrophoresed through an agarose gel, transferred to GeneScreen Plus (DuPont), and hybridized to a a2P-labeled Raly cDNA probe. A nondistinct fragment of -1.2 kb is present in the blastocyst sample (lane 1}, which is consistent with a comigration of the two expected fragments of 1144 and 1227 bp (the region of a sequence polymorphism between M. musculus and M. spretus [sequence analysis of a portion of the 5'-untranslated region of the wild-type Raly gene from both species revealed that M. musculus has a "g" at nucleotide 175 (complement of sequence in Fig. 2 ), which is replaced by a "t" in M. spretus (Fig. 6, first two panels) [. For this purpose, M. musculus females (AY/a) were mated to M. spretus males (A/A) to produce the F1 hybrids A• (distinguished from a/A littermates by their solid yellow pelage). Total RNA from both the AY/A and a/A F 1 hybrids was prepared from day-10 neonate skin, reverse transcribed, and oligonucleotide primers corresponding to base pairs 108-127 and the reverse complement of base pairs 457--438 (Fig. 2) were used to PCR-amplify the 5' portion of the Raly mRNA containing the sequence polymorphism at position 175. The PCR-amplified fragments were then gel-isolated and directly sequenced.
The AY/A F1 hybrid has a "t" at position 175, indicating that Raly is expressed only from the M. spretus allele (A) and not from the M. musculus allele (A y) (Fig. 6, third  panel) . The a/A F~ hybrid, which should express the wild-type Raly of both species, served as a control for this experiment and, as expected, has both a "g" and a "t" comigrating at position 175. The analysis of the a/A control indicated that Raly is capable of being expressed from both the M. musculus (a) and M. spretus (A) alleles (Fig. 6 , last panel) and that our assay can detect the simultaneous expression of these two forms of the gene.
The A y transcription unit forms unique transcripts that are alternately spliced at the 5' end
Because Raly is alternately processed at its 5' end, we also tested for alternative processing in the A y transcription unit with an RT-PCR assay similar to the one used above for Raly. In this case, however, we used an oligonucleotide primer from the first exon of Raly coupled with a primer from the third exon of agouti (Fig. 7) . Results indicated that three different-sized PCR fragments of 284, 395, and 441 bp were produced (Fig. 7) , all of which were of the same approximate abundance in adult spleen and brain (the tissues examined to date in this manner; data not shown). These three PCR fragments were subcloned and sequenced, revealing that each differs at its 5' end and that the alternate processing of the A y transcription unit occurs in a unique manner compared with Raly (Fig. 7) . The 5' end of the first form contains sequence derived from a region referred to as Raly exon I; the second form contains Raly exon I and an additional 111-base segment; and the third form contains Raly exon I, the 111-base segment, and an additional 46-base segment. Each of these different 5' ends is spliced to sequence derived from the second, third, and fourth agouti exons, which contain the entire coding region of the a gene (Fig. 7) .
A feature in common to all of the A y and Raly transcripts that we have identified is the presence of sequence derived from Raly exon I. This Raly sequence was identified as an exon by comparing the wild-type cDNA sequence with genomic clones and is considered to be the first Raly exon because it is present at the 5' end of all cDNA clones characterized thus far. Interestingly, the 83-base segment that is alternately processed 
The embryonic lethality of A• y mice may be the result of the disruption of Raly, and not the ectopic overexpression of the agouti protein
Viable yellow (A Fy) is another dominant a locus mutation that confers the same suite of pleiotropic effects as A y (for review, see Wolff et al. 1986; Wolff 1987) ; how- ever, as the name suggests, AVy/A TM mice are viable. As a first step in analyzing the molecular nature of the A TM mutation, we tested for the expression of the agouti m R N A in several adult tissues of an A TM heterozygote. We found that A TM mice, like A • mice, ectopically overexpress agouti. However, unlike A y, the transcript size of A TM is the same as that from the wild-type allele (Fig. 8). tial manner, which includes the blastocyst, and that it normally produces two alternatively spliced mRNAs that are -1 . 6 kb in length. Raly has the potential to encode a protein that has striking amino acid sequence similarity to the RNA-binding domain of vertebrate hnRNP C proteins (Swanson et al. 1987; Preugschat and 
D i s c u s s i o n
The A y m u t a t i o n at the a locus in mouse chromosome 2 confers a number of d o m i n a n t pleiotropic effects in heterozygotes and results in the preimplantation lethality of homozygous embryos. The dominant pleiotropic effects and recessive embryonic lethality associated with A y have been studied intensively for several decades, but the molecular nature of the underlying defects has remained elusive. As part of our recent molecular characterization of the a gene, we identified a size-altered agouti m R N A associated with the A y allele (Bultman et al. 1992 ). This larger-than-normal A y transcript contains the entire coding region of the a gene, but the untranslated first exon has been replaced by novel sequence (Bultman et al. 1992) . Here, we demonstrate that at least a portion of this novel sequence in the A y transcript corresponds to the 5' region of Raly, another gene that is tightly linked to a. Moreover, we have determined that
Raly is normally expressed in a broad temporal and spa- Figure 8 . Northern blot analysis of a locus expression in tissues of adult viable yellow (A TM) mice. The wild-type a cDNA clone was 32P-labeled and hybridized to poly{A) + RNA {2.5 ~g per lane) from a variety of adult A TM tissues and to wild-type agouti (day-4 neonate skin) and lethal yellow (adult liver) controls. RNA molecular size standards are shown at left in kb. Burd et al. 1989) , which avidly bind to RNA and are probably involved in the processing of hnRNA within the nucleus of the cell. Most importantly, we have determined that Raly is not expressed from the A y allele, and we therefore propose that Raly is a good candidate for the recessive embryonic lethality of a y.
Cold Spring
The precise nature of the DNA structural alteration that generated the A y allele is not yet clear. We do know that the rearrangement involves two closely linked genes, Raly and a, and that a deletion has removed at least a portion of the 3' end of Raly but has not altered the genomic DNA structure at the a locus. Our current working hypothesis for the A y allele is that a deletion removed the coding exons of the Raly gene but has not affected the promoter and 5'-noncoding sequences. In this scenario, transcription would initiate normally at the Raly promoter, but because the 3' end of the Raly gene is deleted, transcription would proceed into the intergenic region and through the downstream a gene. The resulting large primary transcript would be spliced in such a manner that the intergenic DNA and the first exon of the a gene would be recognized as an "intron," because the next available splice acceptor for the splice donor at the 5' end of Raly would be provided by the 3' end of the first intron of the a gene. The processed transcript would be expected to contain the 5'-noncoding exon of Raly and the second, third, and fourth exons of agouti, which is precisely the nature of one of the A yspecific transcripts described in this paper. Physical mapping analyses of the Raly and a loci in the A y allele are currently in progress and should provide direct evidence to support or refute this working model.
Previously, we reported that the wild-type agouti 0.8-kb mRNA is expressed specifically within the skin of the neonate, whereas the A • allele ectopically overexpresses a 1.1-kb agouti mRNA in a variety of tissues of the adult animal (Bultman et al. 1992) . We demonstrated further that the increased size of the A y transcript is the result of a rearrangement upstream of the agouti translation initiation codon and that A y retains the potential to encode the wild-type agouti protein. On the basis of these observations, and the likelihood that the agouti protein is a secreted ligand, we proposed that the A y allele ectopically overexpresses the wild-type agouti protein, leading to the dominant pleiotropic effects associated with A y (Bultman et al. 1992 ). However, after sequencing the heterogeneous 5' ends of several A y cDNA clones (Fig. 7) , we discovered that two of the three different forms of the A y transcript have in-frame ORFs that continue from the agouti translation initiation codon to the 5' end of the cloned portion of the transcript. Therefore, we must entertain the possibility that a fusion protein is generated from at least some forms of the A y transcript. Because no ATG codons are present in the upstream sequence that we have characterized thus far, we continue to favor the hypothesis that the A y transcription unit produces only a wild-type agouti protein. Antibodies to the agouti protein and further analysis of the 5' end of the A y transcript to search for additional ATG codons should facilitate the resolution of this uncertainty.
The characterization of the A vy allele lends further support to the idea that the pleiotropic effects associated with A y result from the ectopic overexpression of the wild-type agouti protein. The A "y allele causes the same dominant pleiotropic effects as A y and also ectopically overexpresses the agouti mRNA. Unlike A y, however, the A vy transcript is the same size as the wild-type agouti transcript, suggesting that a Fy expresses the wild-type agouti protein from this normal-sized transcript. Experiments are currently under way to characterize the molecular nature of the A ~ mutation.
Whereas the ectopic overexpression of the agouti protein may be responsible for the dominant pleiotropic effects associated with A y and A vy, this is unlikely to be the cause of the recessive embryonic lethality associated with A y. Not unexpectedly, the A y allele expresses the agouti mRNA in the same broad temporal and spatial pattern as observed for the wild-type Raly gene product because the a gene is under the control of the Raly promoter in the A y allele. On the basis of our finding that Raly is expressed in the blastocyst, it is reasonable to deduce that the agouti mRNA is expressed from the A y allele in the blastocyst of A y heterozygotes. Following this line of reasoning, it is unlikely that the ectopic overexpression of the agouti gene product is responsible for the embryonic lethality of A y. If this were the case, then embryos heterozygous for A • would also be expected to show some early developmental phenotype, and they do not. A dosage-effect argument could be invoked in which two agouti-expressing A y alleles, not just one, are necessary to induce the recessive lethality of A y. However, because Raly is associated with the A y mutation and is inactivated in the A y allele, we favor the altemative possibility that A y homozygotes fail to develop beyond the blastocyst stage as a result of their inability to produce the Raly gene product. This hypothesis is consistent with the recessive nature of the embryonic lethality. Because we have not yet fully characterized the structural alteration associated with the A y allele, we cannot rule out the possibility that a gene(s) other than Raly has also been affected by the A y mutation and contributes to the lethality phenotype. The definitive experiment to determine whether the loss of Raly expression alone is directly responsible for the prenatal lethality of AY/A y mice is to rescue the lethal phenotype with the wild-type Raly gene in transgenic mice, and this work is currently in progress.
The observation that the Raly gene encodes a protein with an amino terminus that has 77% sequence identity to the RNA-binding domain of the hnRNP C proteins provides a framework with which to speculate about its biochemical function in the early embryo. There are at least 20 abundant hnRNP proteins present in the vertebrate cell nucleus that are physically associated with nascent hnRNA transcripts to form hnRNP complexes (Dreyfuss 1986; Pifiol-Roma et al. 1988; Bennett et al. 1992) . The post-transcriptional processing of hnRNA into mRNA is believed to occur within these hnRNP complexes. The hnRNP proteins have been shown to bind to pre-mRNAs in a sequence-dependent manner. Notably, the hnRNP C proteins bind to the 3' end of introns and to sequences downstream of polyadenylation cleavage sites (Wilusz et al. 1988) , suggesting that they may have a role in premRNA processing. However, relatively little is known about the precise physiological functions of hnRNP proteins.
The recent cloning and sequencing of cDNAs for a number of hnRNP proteins revealed that many of them contain one or two putative RBDs of -90 amino acids. In addition to the hnRNP proteins, a whole host of nuclear and cytoplasmic RNA-binding proteins contain one or more of these 90 residue RBDs that are evolutionarily conserved from yeast to man. Comparisons of these various proteins revealed that the most highly conserved portions of the RBD are an octapeptide (RNP 1) and a hexapeptide (RNP 2) (for review, see Dreyfuss et al. 1988; Bandziulis et al. 1989) .
The RNP consensus sequences (RNP 1 and RNP 2) have also been found in the deduced proteins of several different developmental regulatory genes of Drosophila. For example, the genes sex-lethal (Bell et al. 1988 ) and transformer-2 (Amrein et al. 1988 ) regulate somatic sexual development, and the genes elav (embryonic lethal, abnormal visual system; Robinow et al. 1988 ) and couch potato (Bellen et al. 1992 ) are involved in the normal development and maintenance of the nervous system. Based on the presence of RNP consensus motifs in each of these gene products and the observation that these genes most likely exert their regulatory effects at the post-transcriptional level, it has been suggested that these genes regulate development by controlling the RNA processing of other genes that directly participate in establishing the somatic sexual and neuronal developmental pathways (Bandziulis et al. 1989) .
The striking sequence similarity between the Raly and hnRNP C proteins suggests that Raly may be functioning in the processing of mRNA in the preimplantation embryo. On the basis of the observation that the embryonic lethality of A • may occur as late as implantation, it is possible that Raly is not involved in the generalized RNA processing of most or all of the genes produced in the early embryo. If this were the case, embryonic lethality would probably occur much earlier, as de novo transcription begins in the two-cell embryo of the mouse and most maternal mRNA in the embryo is degraded at this time (for review, see Schultz 1986) . Therefore, it is conceivable that Raly may have a specific regulatory function later in development that somehow relates to the maturation of the blastocyst. On the other hand, it may turn out that Raly is essential for generalized processing of transcripts in the early embryo and that enough Raly protein from maternal mRNA persists in the early embryo to allow development to the blastocyst stage. Experiments are currently under way to address this issue.
Materials and methods
Animals
All mice were maintained at the Oak Ridge National Laboratory. The A vy mice represent a new spontaneous mutation from the Jackson Laboratory (Bar Harbor, ME) that we determined is homozygous viable and appears to be genetically identical to the classical A Fy allele (E.J. Michaud, S.J. Bultman, M.T. Davisson, and R.P. Woychik, in prep.).
RNA analysis
Total cellular RNA from all tissues (except blastocysts) was extracted using the guanidine isothiocyanate procedure (Ausubel et al. 1988) , enriched for poly(A) + RNA using an oligo(dT)-cellulose column (Aviv and Leder 1972) , electrophoresed through formaldehyde gels, and blotted to GeneScreen (DuPont) using standard procedures (Ausubel et al. 1988) . Radiolabeled hybridization probes were prepared with the random hexamer-labeling technique (Feinberg and Vogelstein 1984) . Posthybridization filter washes were conducted at high stringency (0.2x SSC, 0.1% SDS at 68~ unless otherwise noted. Reduced stringency washes were conducted at 0.2x SSC, 0.1% SDS, and 50~
Total cellular RNA from blastocysts was prepared as described by Rothstein et al. (1992) .
For RT-PCR analyses, 8 ~g of total RNA was reverse transcribed (Kawasaki 1990) , ethanol precipitated, and resuspended in 20 ~l of H20, and PCR analysis was performed with 2 ~1 of the sample as described previously (Pieretti et al. 1991) .
Isolation of cDNA clones
Total RNA was prepared from AY/a e adult kidney, and doublestranded cDNA was prepared by standard procedures (Sambrook et al. 1989) . After the addition of EcoRI linkers, the eDNA was ligated into the Kgtl0 vector (Stratagene), packaged in vitro, and screened with a 32p-labeled wild-type agouti cDNA probe (Fig. 2 in Bultman et al. 1992 ) using standard procedures (Sambrook et al. 1989 ). Positive clones were purified and subcloned into pBluescript (Stratagene) for further analysis. Raly cDNA clones were isolated from a C57BL/6 day 8.5 whole-embryo library (Fahrner et al. 1987 ) by screening with 32p-labeled probe A (Figs. 1 and 2), and positive clones were purified and subcloned into pBluescript (Stratagene).
Southern blot analysis
Genomic DNA (10 ~g) was digested with restriction enzymes, electrophoresed through agarose gels, and blotted to GeneScreen (DuPont) using standard procedures (Ausubel et al. 1988; Sambrook et al. 1989) . Radiolabeled hybridization probes were prepared with the random hexamer-labeling technique (Feinberg and Vogelstein 1984) . Repetitive sequences present in probe 1.5 were reassociated with sheared, genomic mouse DNA before hybridization. Posthybridization filter washes were conducted at high stringency (0.2x SSC, 0.1% SDS, and 68~
Isolation of genomic clones
Genomic liver DNA from the strain FVB/N was partially digested with Sau3A and size fractionated on a 10-40% sucrose gradient (Sambrook et al. 1989) . Fractions containing 18-to 23-kb fragments were ligated into the ~ vector, EMBL3 (Stratagene), packaged in vitro, and screened with 32P-labeled probe A (Figs. 1 and 2) using standard procedures (Sambrook et al. 1989) . Positive clones were purified and subcloned into pBluescript (Stratagene).
DNA sequencing
Genomic and cDNA clones were sequenced by the Sanger dideoxynucleotide method (Sanger et al. 1977 ) using T7 DNA Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genesdev.cshlp.org Downloaded from polymerase (U.S. Biochemical) (Tabor and Richardson 1987) . For direct sequencing of RT-PCR-amplified cDNA from the M. musculus/M, spretus hybrids, the Sanger dideoxynucleotide method was used along with a modified PCR-template protocol as described (Winship 1989) . Analysis of DNA sequence was performed using the University of Wisconsin Genetics Computing Group sequence analysis programs (Devereux et al. 1984) .
